fda warning letters compounded semaglutide 2025 september Concerns Surrounding GLP-1s Mount As Shortages of Tirzepatide, End The FDA has issued warning

These medicines only deliver their trial-proven benefits when they remain chemically intact, which depends on correct cold-chain storage

Many women worry that weight-loss medications may be less effective once these hormonal changes begin

Here are the key options worth knowing about

doi: 10.1210/en.2012-1786 [DOI] [PubMed] [Google Scholar] 75.Altintas Dogan AD, Hilberg O, Hess S, Jensen TT, Bladbjerg E, Juhl CB

In short, the benefits were real, but so were the risks, underscoring the need for individualized care, expert supervision, and close follow-up when using these medications in teens

Link here: Available medicines or the upcoming ones can assist with significant weight loss, but they are most effectiveand intended for useas an adjunct to, not a replacement for, lifestyle modification